Market revenue in 2023 | USD 6,222.1 million |
Market revenue in 2030 | USD 32,516.6 million |
Growth rate | 26.6% (CAGR from 2023 to 2030) |
Largest segment | Diabetes |
Fastest growing segment | Diabetes |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diabetes, Obesity, CVD, Respiratory Diseases, Smoking Cessation, CNS Diseases |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital therapeutics market will help companies and investors design strategic landscapes.
diabetes was the largest segment with a revenue share of 29.36% in 2023. Horizon Databook has segmented the Global digital therapeutics market based on diabetes, obesity, cvd, respiratory diseases, smoking cessation, cns diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Growing regulatory initiatives are anticipated to propel standardization and R&D in the market over the forecast period. For instance, the Software Pre-Cert Pilot Program is part of the Digital Health Innovation Action Plan of the FDA intended for implying a more efficient governing oversight of software-based medical devices (SaMD) developed by manufacturers.
The program is aimed at developing an efficient regulatory oversight for assessing organizations to establish trust that they can develop high-quality Software-as-a-Medical-Device (SaMD) products. For instance, initiatives, such as the National Digital Health Mission (NDHM), are expected to accelerate the adoption rate of e-healthcare model in India.
Similarly, the &Innovation Strategy 2019-2021& implemented in UAE is driving digital transformation in the healthcare sector.In September 2020, the FDA released a status update for its Software Precertification Program. In this, the FDA specified that it has developed and tested components for the Pre-Cert model and will continue assessing how to integrate the components into a viable product lifecycle approach.
Horizon Databook provides a detailed overview of global-level data and insights on the Global digital therapeutics market , including forecasts for subscribers. This global databook contains high-level insights into Global digital therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account